Actavis Acquiring Warner Chilcott For $8.5 BillionMani
Actavis Inc (NYSE:ACT) today announced its definitive agreement to acquire Warner Chilcott plc (NASDAQ:WCRX) in an all stock transaction valued at approximately $8.5 billion.
Actavis, Warner Chilcott Deal:
The generic drug maker Actavis Inc (NYSE:ACT) is to acquire the specialty pharmaceutical company Warner Chilcott.
The deal means that Warner Chilcott shareholders to receive 0.16 shares of Actavis for each Warner Chilcott plc . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible